| # | Drug | Count |
|---|---|---|
| 0 | RITONAVIR | 61 |
| 1 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 52 |
| 2 | DARUNAVIR | 37 |
| 3 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 36 |
| 4 | RITONAVIR 100 MG | 32 |
| 5 | LAMIVUDINE | 29 |
| 6 | RILPIVIRINE | 27 |
| 7 | DOLUTEGRAVIR SODIUM | 26 |
| 8 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 25 |
| 9 | METHOTREXATE SODIUM | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRYONIA (ALBA), CARDUUS MARIANUS, CHELIDONIUM MAJUS, HEPAR SUIS, TARAXACUM OFFICINALE | 1 | 0.0769 |
| 1 | AMYL NITRITE | 2 | 0.0333 |
| 2 | BENZETHONIUM CHLORIDE | 2 | 0.0155 |
| 3 | CABOTEGRAVIR SODIUM | 19 | 0.0118 |
| 4 | PENICILLIN G BENZATHINE | 13 | 0.0095 |
| 5 | PAROMOMYCIN SULFATE | 1 | 0.0094 |
| 6 | SECNIDAZOLE | 2 | 0.0071 |
| 7 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 25 | 0.0069 |
| 8 | GRISEOFULVIN | 2 | 0.0069 |
| 9 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tubulin Inhibiting Agent [EPC] | 2 | 0.0069 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 8 | 0.0035 |
| 2 | Protease Inhibitor [EPC] | 79 | 0.0018 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 91 | 0.0015 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 152 | 0.0014 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 67 | 0.0014 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 29 | 0.0012 |
| 7 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 8 | Antimalarial [EPC] | 10 | 0.0010 |
| 9 | Antiprotozoal [EPC] | 10 | 0.0009 |